Deep Learning in Cardiology

The medical field is creating large amount of data that physicians are unable to decipher and use efficiently. Moreover, rule-based expert systems are inefficient in solving complicated medical tasks or for creating insights using big data. Deep learning has emerged as a more accurate and effective technology in a wide range of medical problems such as diagnosis, prediction and intervention. Deep learning is a representation learning method that consists of layers that transform the data non-linearly, thus, revealing hierarchical relationships and structures. In this review we survey deep learning application papers that use structured data, signal and imaging modalities from cardiology. We discuss the advantages and limitations of applying deep learning in cardiology that also apply in medicine in general, while proposing certain directions as the most viable for clinical use.Comment: 27 pages, 2 figures, 10 table

Four-Dimensional Flow Magnetic Resonance Imaging and Applications in Cardiology

Blood flow through the heart and great vessels moves in three dimensions (3D) throughout time. However, the assessment of its 3D nature has been limited in the human body. Recent advances in magnetic resonance imaging (MRI) allow for the comprehensive visualization and quantification of in-vivo flow dynamics using four-dimensional (4D) flow MRI. In addition, this technique provides the opportunity to obtain advanced hemodynamic biomarkers such as vorticity, helicity, wall shear stress (WSS), pressure gradients, viscous energy loss (EL), and turbulent kinetic energy (TKE). This chapter will introduce 4D flow MRI which is currently used for blood flow visualization and advanced quantification of cardiac hemodynamic biomarkers. We will discuss its advantages relative to other in-vivo flow imaging techniques and describe its potential clinical applications in cardiology

S-Net: a multiple cross aggregation convolutional architecture for automatic segmentation of small/thin structures for cardiovascular applications

With the success of U-Net or its variants in automatic medical image segmentation, building a fully convolutional network (FCN) based on an encoder-decoder structure has become an effective end-to-end learning approach. However, the intrinsic property of FCNs is that as the encoder deepens, higher-level features are learned, and the receptive field size of the network increases, which results in unsatisfactory performance for detecting low-level small/thin structures such as atrial walls and small arteries. To address this issue, we propose to keep the different encoding layer features at their original sizes to constrain the receptive field from increasing as the network goes deeper. Accordingly, we develop a novel S-shaped multiple cross-aggregation segmentation architecture named S-Net, which has two branches in the encoding stage, i.e., a resampling branch to capture low-level fine-grained details and thin/small structures and a downsampling branch to learn high-level discriminative knowledge. In particular, these two branches learn complementary features by residual cross-aggregation; the fusion of the complementary features from different decoding layers can be effectively accomplished through lateral connections. Meanwhile, we perform supervised prediction at all decoding layers to incorporate coarse-level features with high semantic meaning and fine-level features with high localization capability to detect multi-scale structures, especially for small/thin volumes fully. To validate the effectiveness of our S-Net, we conducted extensive experiments on the segmentation of cardiac wall and intracranial aneurysm (IA) vasculature, and quantitative and qualitative evaluations demonstrated the superior performance of our method for predicting small/thin structures in medical images

Deep learning tools for outcome prediction in a trial fibrilation from cardiac MRI

Tese de mestrado integrado em Engenharia Biomédica e Biofísica (Engenharia Clínica e Instrumentação Médica), Universidade de Lisboa, Faculdade de Ciências, 2021Atrial fibrillation (AF), is the most frequent sustained cardiac arrhythmia, described by an irregular and rapid contraction of the two upper chambers of the heart (the atria). AF development is promoted and predisposed by atrial dilation, which is a consequence of atria adaptation to AF. However, it is not clear whether atrial dilation appears similarly over the cardiac cycle and how it affects ventricular volumes. Catheter ablation is arguably the AF gold standard treatment. In their current form, ablations are capable of directly terminating AF in selected patients but are only first-time effective in approximately 50% of the cases. In the first part of this work, volumetric functional markers of the left atrium (LA) and left ventricle (LV) of AF patients were studied. More precisely, a customised convolutional neural network (CNN) was proposed to segment, across the cardiac cycle, the LA from short axis CINE MRI images acquired with full cardiac coverage in AF patients. Using the proposed automatic LA segmentation, volumetric time curves were plotted and ejection fractions (EF) were automatically calculated for both chambers. The second part of the project was dedicated to developing classification models based on cardiac MR images. The EMIDEC STACOM 2020 challenge was used as an initial project and basis to create binary classifiers based on fully automatic classification neural networks (NNs), since it presented a relatively simple binary classification task (presence/absence of disease) and a large dataset. For the challenge, a deep learning NN was proposed to automatically classify myocardial disease from delayed enhancement cardiac MR (DE-CMR) and patient clinical information. The highest classification accuracy (100%) was achieved with Clinic-NET+, a NN that used information from images, segmentations and clinical annotations. For the final goal of this project, the previously referred NNs were re-trained to predict AF recurrence after catheter ablation (CA) in AF patients using pre-ablation LA short axis in CINE MRI images. In this task, the best overall performance was achieved by Clinic-NET+ with a test accuracy of 88%. This work shown the potential of NNs to interpret and extract clinical information from cardiac MRI. If more data is available, in the future, these methods can potentially be used to help and guide clinical AF prognosis and diagnosis

Contribuciones de las técnicas machine learning a la cardiología. Predicción de reestenosis tras implante de stent coronario

[ES]Antecedentes: Existen pocos temas de actualidad equiparables a la posibilidad de la tecnología actual para desarrollar las mismas capacidades que el ser humano, incluso en medicina. Esta capacidad de simular los procesos de inteligencia humana por parte de máquinas o sistemas informáticos es lo que conocemos hoy en día como inteligencia artificial. Uno de los campos de la inteligencia artificial con mayor aplicación a día de hoy en medicina es el de la predicción, recomendación o diagnóstico, donde se aplican las técnicas machine learning. Asimismo, existe un creciente interés en las técnicas de medicina de precisión, donde las técnicas machine learning pueden ofrecer atención médica individualizada a cada paciente. El intervencionismo coronario percutáneo (ICP) con stent se ha convertido en una práctica habitual en la revascularización de los vasos coronarios con enfermedad aterosclerótica obstructiva significativa. El ICP es asimismo patrón oro de tratamiento en pacientes con infarto agudo de miocardio; reduciendo las tasas de muerte e isquemia recurrente en comparación con el tratamiento médico. El éxito a largo plazo del procedimiento está limitado por la reestenosis del stent, un proceso patológico que provoca un estrechamiento arterial recurrente en el sitio de la ICP. Identificar qué pacientes harán reestenosis es un desafío clínico importante; ya que puede manifestarse como un nuevo infarto agudo de miocardio o forzar una nueva resvascularización del vaso afectado, y que en casos de reestenosis recurrente representa un reto terapéutico. Objetivos: Después de realizar una revisión de las técnicas de inteligencia artificial aplicadas a la medicina y con mayor profundidad, de las técnicas machine learning aplicadas a la cardiología, el objetivo principal de esta tesis doctoral ha sido desarrollar un modelo machine learning para predecir la aparición de reestenosis en pacientes con infarto agudo de miocardio sometidos a ICP con implante de un stent. Asimismo, han sido objetivos secundarios comparar el modelo desarrollado con machine learning con los scores clásicos de riesgo de reestenosis utilizados hasta la fecha; y desarrollar un software que permita trasladar esta contribución a la práctica clínica diaria de forma sencilla. Para desarrollar un modelo fácilmente aplicable, realizamos nuestras predicciones sin variables adicionales a las obtenidas en la práctica rutinaria. Material: El conjunto de datos, obtenido del ensayo GRACIA-3, consistió en 263 pacientes con características demográficas, clínicas y angiográficas; 23 de ellos presentaron reestenosis a los 12 meses después de la implantación del stent. Todos los desarrollos llevados a cabo se han hecho en Python y se ha utilizado computación en la nube, en concreto AWS (Amazon Web Services). Metodología: Se ha utilizado una metodología para trabajar con conjuntos de datos pequeños y no balanceados, siendo importante el esquema de validación cruzada anidada utilizado, así como la utilización de las curvas PR (precision-recall, exhaustividad-sensibilidad), además de las curvas ROC, para la interpretación de los modelos. Se han entrenado los algoritmos más habituales en la literatura para elegir el que mejor comportamiento ha presentado. Resultados: El modelo con mejores resultados ha sido el desarrollado con un clasificador extremely randomized trees; que superó significativamente (0,77; área bajo la curva ROC a los tres scores clínicos clásicos; PRESTO-1 (0,58), PRESTO-2 (0,58) y TLR (0,62). Las curvas exhaustividad sensibilidad ofrecieron una imagen más precisa del rendimiento del modelo extremely randomized trees que muestra un algoritmo eficiente (0,96) para no reestenosis, con alta exhaustividad y alta sensibilidad. Para un umbral considerado óptimo, de 1,000 pacientes sometidos a implante de stent, nuestro modelo machine learning predeciría correctamente 181 (18%) más casos en comparación con el mejor score de riesgo clásico (TLR). Las variables más importantes clasificadas según su contribución a las predicciones fueron diabetes, enfermedad coronaria en 2 ó más vasos, flujo TIMI post-ICP, plaquetas anormales, trombo post-ICP y colesterol anormal. Finalmente, se ha desarrollado una calculadora para trasladar el modelo a la práctica clínica. La calculadora permite estimar el riesgo individual de cada paciente y situarlo en una zona de riesgo, facilitando la toma de decisión al médico en cuanto al seguimiento adecuado para el mismo. Conclusiones: Aplicado inmediatamente después de la implantación del stent, un modelo machine learning diferencia mejor a aquellos pacientes que presentarán o no reestenosis respecto a los discriminadores clásicos actuales

The Convergence of Human and Artificial Intelligence on Clinical Care - Part I

This edited book contains twelve studies, large and pilots, in five main categories: (i) adaptive imputation to increase the density of clinical data for improving downstream modeling; (ii) machine-learning-empowered diagnosis models; (iii) machine learning models for outcome prediction; (iv) innovative use of AI to improve our understanding of the public view; and (v) understanding of the attitude of providers in trusting insights from AI for complex cases. This collection is an excellent example of how technology can add value in healthcare settings and hints at some of the pressing challenges in the field. Artificial intelligence is gradually becoming a go-to technology in clinical care; therefore, it is important to work collaboratively and to shift from performance-driven outcomes to risk-sensitive model optimization, improved transparency, and better patient representation, to ensure more equitable healthcare for all